Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

Rational Emotive Behavior Therapy

Rational Emotive Behavior Therapy

Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert Ellis's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study.

Psychiatric research and clinical practice·2022

Same author

BLENDS: Augmentation of Functional Magnetic Resonance Images for Machine Learning Using Anatomically Constrained Warping.

Brain connectivity·2022

Same author

Circulating microRNA associated with future relapse status in major depressive disorder.

Frontiers in psychiatry·2022

Same author

Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response.

Biological psychiatry·2022

Same author

Alterations in resting-state functional activity and connectivity for major depressive disorder appetite and weight disturbance phenotypes.

Psychological medicine·2022

Same author

Youth Aware of Mental Health (YAM) Program With Texas Adolescents: Depression, Anxiety, and Substance Use Outcomes.

The Journal of clinical psychiatry·2022

Search research articles

Related Experiment Video

Updated: May 29, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Performance improvement CME: algorithms and EMRs in depression.

Richard C Shelton¹, Madhukar H Trivedi

¹Department of Psychiatry, Vanderbilt School of Medicine, Nashville, Tennessee, USA.

The Journal of Clinical Psychiatry

|September 29, 2011

Summary

Major depressive disorder (MDD) treatment is challenging. Improving outcomes requires understanding antidepressant response moderators, using measurement-based care, and following treatment algorithms for better patient results.

More Related Videos

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Related Experiment Videos

Last Updated: May 29, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Area of Science:

Psychiatry and Clinical Psychology
Pharmacology and Therapeutics

Background:

Major depressive disorder (MDD) presents chronic and recurrent challenges, often with suboptimal pharmacologic treatment efficacy.
Current treatment strategies for MDD necessitate enhanced approaches beyond standard pharmacotherapy.

Discussion:

Clinicians must integrate knowledge of antidepressant response moderators to personalize treatment strategies.
Implementing measurement-based care and adhering to established treatment algorithms are crucial for optimizing patient outcomes.
Electronic medical records (EMRs) and decision support systems can enhance documentation and adherence to care standards.

Key Insights:

Familiarity with moderators of antidepressant response is key to improving treatment effectiveness.
Measurement-based care and treatment algorithms provide a structured framework for managing MDD.
Technological tools like EMRs support consistent application of best practices in antidepressant therapy.

Outlook:

Future research should explore novel moderators and refine treatment algorithms for treatment-resistant depression.
Integration of advanced decision support systems may further personalize and improve antidepressant therapy.
Continued focus on performance improvement activities is essential for advancing MDD patient care.